Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development: A Clinician's Request for a More Integrated Approach

por Allegaert, Karel, Smits, Anne, van den Anker, Johannes N.
Publicado 2012

Perinatal Pharmacology

por Allegaert, Karel, Fanos, Vassilios, van den Anker, Johannes N., Laër, Stephanie
Publicado 2014

Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children

por Rodieux, Frederique, Wilbaux, Melanie, van den Anker, Johannes N., Pfister, Marc
Publicado 2015

Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children

por Fuchs, Aline, Bielicki, Julia, Mathur, Shrey, Sharland, Mike, Van Den Anker, Johannes N.
Publicado 2018

COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment

por Welzel, Tatjana, Samba, Samuel Dembi, Klein, Reinhild, van den Anker, Johannes N., Kuemmerle-Deschner, Jasmin B.
Publicado 2021

Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years

por Ziesenitz, Victoria C., Welzel, Tatjana, van Dyk, Madelé, Saur, Patrick, Gorenflo, Matthias, van den Anker, Johannes N.
Publicado 2022

A Delphi Process to Optimize Quality and Performance of Drug Evaluation in Neonates

por Legrand, Frederic, Boulkedid, Rym, Elie, Valery, Leroux, Stephanie, Valls, Elizabeth, Valls-i-Soler, Adolfo, Van den Anker, Johannes N., Jacqz-Aigrain, Evelyne
Publicado 2014

First‐Pass CYP3A‐Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates

por Brussee, Janneke M., Yu, Huixin, Krekels, Elke H. J., de Roos, Berend, Brill, Margreke J. E., van den Anker, Johannes N., Rostami‐Hodjegan, Amin, de Wildt, Saskia N., Knibbe, Catherijne A. J.
Publicado 2018

Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen

por van Rongen, Anne, Välitalo, Pyry A. J., Peeters, Mariska Y. M., Boerma, Djamila, Huisman, Fokko W., van Ramshorst, Bert, van Dongen, Eric P. A., van den Anker, Johannes N., Knibbe, Catherijne A. J.
Publicado 2016

Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults

por van Rongen, Anne, Brill, Margreke J. E., Vaughns, Janelle D., Välitalo, Pyry A. J., van Dongen, Eric P. A., van Ramshorst, Bert, Barrett, Jeffrey S., van den Anker, Johannes N., Knibbe, Catherijne A. J.
Publicado 2017

Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic review

por van Dyk, Madelé, Boylan, Chelsea, Michelet, Robin, Mc Laughlin, Anna M, Kichenadasse, Ganessan, May, Nikki, Ziesenitz, Victoria, Van Den Anker, Johannes N, Groenland, Stefanie L, Huitema, Alwin D R, Steeghs, Neeltje, Mikus, Gerd, Kloft, Charlotte, Tapp, Heather
Publicado 2022

Predicting CYP3A‐mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure

por Brussee, Janneke M., Vet, Nienke J., Krekels, Elke H. J., Valkenburg, Abraham J., Jacqz‐Aigrain, Evelyne, van Gerven, Joop M. A., Swart, Eleonora L., van den Anker, Johannes N., Tibboel, Dick, de Hoog, Matthijs, de Wildt, Saskia N., Knibbe, Catherijne A. J.
Publicado 2017